|
Volumn 8, Issue 9, 2005, Pages 736-738
|
Challenges of immune responses in gene replacement therapy
|
Author keywords
Gene therapy; Innate immunity; T cell responses; Viral vectors
|
Indexed keywords
ADENOVIRUS VECTOR;
B7 ANTIGEN;
CANCER VACCINE;
CD134 ANTIGEN;
CD28 ANTIGEN;
CD4 ANTIGEN;
CD8 ANTIGEN;
CD86 ANTIGEN;
CYTOKINE;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
DNA;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOSUPPRESSIVE AGENT;
INTERFERON;
INTERLEUKIN 6;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;
PARVOVIRUS VECTOR;
TUMOR NECROSIS FACTOR ALPHA;
VACCINE;
VIRUS ANTIGEN;
VIRUS VECTOR;
ANTIGEN PRESENTING CELL;
ARTICLE;
B LYMPHOCYTE;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
DENDRITIC CELL;
GENE REPLACEMENT THERAPY;
GENE TRANSFER;
GENETIC TRANSCRIPTION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOLOGICAL MEMORY;
IMMUNOREGULATION;
INVERTED TERMINAL REPEAT;
NONHUMAN;
OPEN READING FRAME;
PRIMATE;
T LYMPHOCYTE;
VIRAL GENE DELIVERY SYSTEM;
VIRUS INFECTION;
ANTIGENS, VIRAL;
DENDRITIC CELLS;
GENE THERAPY;
GENETIC VECTORS;
HUMANS;
IMMUNITY, NATURAL;
IMMUNOLOGIC MEMORY;
T-LYMPHOCYTES;
|
EID: 24644497652
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (6)
|